Literature DB >> 25841492

Practical genetics of colorectal cancer.

Henry T Lynch1, Trudy G Shaw2.   

Abstract

Hereditary colorectal cancer (CRC) is highly heterogeneous, both genotypically and phenotypically. The most frequently occurring hereditary colorectal cancer syndrome is Lynch syndrome, accounting for approximately 3% of the total colorectal cancer burden. Polyposis syndromes, such as familial adenomatous polyposis, account for a lesser percentage. Familial colorectal cancer, defined by family history, occurs in an estimated 20% of all colorectal cancer cases. With a worldwide annual colorectal cancer incidence of over one million, and annual mortality of over 600,000, hereditary and familial forms of colorectal cancer are a major public health problem. Lynch syndrome is attributable to DNA mismatch repair germline mutations, with the MSH2, MLH1, MSH6, and PMS2 genes being implicated. The characteristics of Lynch syndrome-associated colorectal tumors, including early age of onset and predilection to the proximal colon, mandate surveillance by colonoscopy beginning by age 20 to 25 and repeated every other year through age 40 and annually thereafter. Besides colorectal cancer, Lynch syndrome also predisposes to a litany of extracolonic cancers, foremost of which is endometrial cancer, followed by cancer of the ovary, stomach, renal pelvis and ureter, small bowel, hepatobiliary tract, pancreas, glioblastoma multiforme in the Turcot's variant, and sebaceous skin tumors in the Muir-Torre variant and, more recently identified, cancers of the breast and prostate. The most common polyposis syndrome is familial adenomatous polyposis, caused by mutations in the APC gene. Affected individuals have multiple colonic adenomas and, without treatment invariably develop colorectal cancer. Colonic surveillance with polypectomy may be pursued until the appearance of multiple colonic adenomas, at which time prophylactic colectomy should be considered. Extra-intestinal manifestations include desmoid tumor, hepatoblastoma, thyroid carcinoma, and medulloblastoma. Other polyposis syndromes include the hamartomatous polyp syndromes, including juvenile polyposis syndrome, Peutz-Jeghers syndrome, Cowden syndrome, and Bannayan-Ruvalcaba-Riley syndrome.

Entities:  

Keywords:  Colorectal cancer (CRC); Lynch syndrome; MYH (MUTYH) mutations; Polyposis syndromes; familial adenomatous polyposis (FAP); gene; genetics

Year:  2013        PMID: 25841492     DOI: 10.3978/j.issn.2304-3865.2013.03.04

Source DB:  PubMed          Journal:  Chin Clin Oncol        ISSN: 2304-3865


  7 in total

Review 1.  Molecular approach to genetic and epigenetic pathogenesis of early-onset colorectal cancer.

Authors:  Gulcin Tezcan; Berrin Tunca; Secil Ak; Gulsah Cecener; Unal Egeli
Journal:  World J Gastrointest Oncol       Date:  2016-01-15

2.  Mismatch repair single nucleotide polymorphisms and thyroid cancer susceptibility.

Authors:  Luís S Santos; Susana N Silva; Octávia M Gil; Teresa C Ferreira; Edward Limbert; José Rueff
Journal:  Oncol Lett       Date:  2018-02-21       Impact factor: 2.967

Review 3.  Genetics of colorectal cancer.

Authors:  I Munteanu; B Mastalier
Journal:  J Med Life       Date:  2014 Oct-Dec

4.  New insights on familial colorectal cancer type X syndrome.

Authors:  Felipe Antonio de Oliveira Garcia; Edilene Santos de Andrade; Henrique de Campos Reis Galvão; Cristina da Silva Sábato; Natália Campacci; Andre Escremin de Paula; Adriane Feijó Evangelista; Iara Viana Vidigal Santana; Matias Eliseo Melendez; Rui Manuel Reis; Edenir Inez Palmero
Journal:  Sci Rep       Date:  2022-02-18       Impact factor: 4.379

Review 5.  Extracellular Nucleic Acids in the Diagnosis and Progression of Colorectal Cancer.

Authors:  Jakub Styk; Gergely Buglyó; Ondrej Pös; Ádám Csók; Beáta Soltész; Peter Lukasz; Vanda Repiská; Bálint Nagy; Tomáš Szemes
Journal:  Cancers (Basel)       Date:  2022-07-29       Impact factor: 6.575

Review 6.  Microsatellite instability in colorectal cancer.

Authors:  Jafar Nouri Nojadeh; Shahin Behrouz Sharif; Ebrahim Sakhinia
Journal:  EXCLI J       Date:  2018-01-22       Impact factor: 4.068

7.  Contribution of MLH1 constitutional methylation for Lynch syndrome diagnosis in patients with tumor MLH1 downregulation.

Authors:  Diana Pinto; Carla Pinto; Joana Guerra; Manuela Pinheiro; Rui Santos; Hege Marie Vedeld; Zeremariam Yohannes; Ana Peixoto; Catarina Santos; Pedro Pinto; Paula Lopes; Ragnhild Lothe; Guro Elisabeth Lind; Rui Henrique; Manuel R Teixeira
Journal:  Cancer Med       Date:  2018-01-17       Impact factor: 4.452

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.